West Roxbury, MA, United States of America

Hongshan Li

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mcgill University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongshan Li. Retrieved from https://idiyas.com/inventor/hongshan-li-sgnui9th

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hongshan Li in Chagas Disease Research

Introduction

Hongshan Li is an accomplished inventor based in West Roxbury, MA (US). He has made significant contributions to the field of medical research, particularly in the diagnosis of Chagas disease. His innovative work focuses on the development of protein-based biomarkers that can aid in the classification of Chagas disease status in patients.

Latest Patents

Hongshan Li holds a patent for "Serum biomarkers for Chagas disease." This invention provides a set of protein-based biomarkers and biomarker combinations that are instrumental in determining whether a patient is infected with Chagas disease or not. The biomarkers can be effectively detected using SELDI mass spectrometry, offering a reliable method for diagnosis.

Career Highlights

Li is affiliated with McGill University, where he continues to advance his research in the field of infectious diseases. His work has garnered attention for its potential to improve patient outcomes through early and accurate diagnosis.

Collaborations

Some of his notable coworkers include Vladimir Podust and Terence William Spithill. Their collaborative efforts contribute to the ongoing research and development of innovative solutions in the medical field.

Conclusion

Hongshan Li's contributions to the understanding and diagnosis of Chagas disease through his patented biomarkers represent a significant advancement in medical research. His work exemplifies the impact of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…